AXIM Biotechnologies, Inc.
AXIM · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $2,003 | $1,256 | $606 | $1,514 |
| - Cash | $3 | $7 | $0 | $1 |
| + Debt | $7,545 | $7,384 | $6,641 | $7,011 |
| Enterprise Value | $9,546 | $8,633 | $7,246 | $8,525 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$108 | $0 | -$116 | -$106 |
| % Margin | – | – | – | – |
| EBITDA | $328 | -$53 | -$214 | -$352 |
| % Margin | – | – | – | – |
| Net Income | $136 | -$234 | -$417 | -$534 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0.001 | -0.001 | -0.002 |
| % Growth | 157.1% | 46.2% | 27.8% | – |
| Operating Cash Flow | -$674 | -$133 | -$78 | -$263 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$674 | -$133 | -$78 | -$263 |